Document is current
Any future updates will be listed below
-
Authors
Petrochuk, Jessica
Pai, Suraj
He, John
Haugg, Fridolin
Xu, Yiwen
Christiani, David
Mak, Raymond
Aerts, Hugo
-
Funding
Funding for this research was provided by:
NI (5U01CA209414, 5U01CA209414, 5U01CA209414)
NIH-USA (U24CA194354)
- License Information
-
More Information
Article History
Received: 4 July 2025
Accepted: 28 October 2025
First Online: 3 December 2025
Declarations
:
: RHM: Advisory Board (ViewRay, AstraZeneca), Consulting (AstraZeneca, Varian Medical Systems, Sio Capital Management), Honorarium (Novartis, Springer Nature), Research Funding (National Institute of Health, ViewRay, AstraZeneca, Siemens Medical Solutions USA, Inc, Varian Medical Systems). HJWLA reports consulting fees from Onc.AI, Love Health, and Sphera, and stock from Onc.AI, Sphera, Love Health, Health-AI, Ambient, and AstraZeneca, outside the submitted work. All other authors do not have any competing interests.
